In CD34-negative AML, we standardized the ALDH-MFI values of normal stem cell candidates and CD34– neoplastic cells by dividing these by the ALDH-MFI value of lymphocytes present within the same AML sample (Table S2). This evidence concerns the gene LDHA and acute myeloid leukemia.